Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
NexImmune, Inc. (NEXI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
4
| Verstandig Grant (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 44,983 options to buy
@ $0.29, valued at
$13k
|
|
| 07/07/2023 |
4
| Gandhi Leena (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 44,983 options to buy
@ $0.29, valued at
$13k
|
|
| 07/07/2023 |
4
| Yao Zhengbin (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 44,983 options to buy
@ $0.29, valued at
$13k
|
|
| 07/07/2023 |
4
| Roemer Alan S. (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 44,983 options to buy
@ $0.29, valued at
$13k
|
|
| 07/07/2023 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 44,983 options to buy
@ $0.29, valued at
$13k
|
|
| 07/07/2023 |
4
| D'Angio Paul (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 44,983 options to buy
@ $0.29, valued at
$13k
|
|
| 07/07/2023 |
4
| Bertram Timothy (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 44,983 options to buy
@ $0.29, valued at
$13k
|
|
| 03/31/2023 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 400,000 shares
@ $0.4103, valued at
$164.1k
|
|
| 11/29/2022 |
4
| Jones Kristi (President and CEO) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 296,700 shares
@ $0 |
|
| 11/25/2022 |
4
| Trainer John (CFO) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 125,200 shares
@ $0 |
|
| 11/25/2022 |
4
| OELKE MATHIAS (Chief Science Officer) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 126,100 shares
@ $0 |
|
| 11/17/2022 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 75,000 shares
@ $0.4789, valued at
$35.9k
Bought 125,000 shares
@ $0.4824, valued at
$60.3k
|
|
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| D'Angio Paul (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 61,678 options to buy
@ $1.82, valued at
$112.3k
|
|
| 06/15/2022 |
4
| Roemer Alan S. (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 61,678 options to buy
@ $1.82, valued at
$112.3k
|
|
| 06/15/2022 |
4
| Verstandig Grant (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 61,678 options to buy
@ $1.82, valued at
$112.3k
|
|
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Verstandig Grant (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 26,876 shares
@ $2.284, valued at
$61.4k
Bought 25,000 shares
@ $2.1415, valued at
$53.5k
Bought 15,000 shares
@ $2.2249, valued at
$33.4k
|
|
| 06/02/2022 |
4
| Verstandig Grant (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 47,900 shares
@ $2.2272, valued at
$106.7k
Bought 40,200 shares
@ $2.3821, valued at
$95.8k
Bought 45,024 shares
@ $2.1126, valued at
$95.1k
|
|
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/07/2022 |
4
| OELKE MATHIAS (Chief Science Officer) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 60,000 options to buy
@ $4.22, valued at
$253.2k
|
|
| 04/07/2022 |
4
| Jones Kristi (President and CEO) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 456,000 options to buy
@ $4.22, valued at
$1.9M
|
|
| 04/07/2022 |
4
| Knight Robert Douglas (Chief Medical Officer) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 48,000 options to buy
@ $4.22, valued at
$202.6k
|
|
| 04/07/2022 |
4
| ZELDIS JEROME B (Executive VP of Research & Dev) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 80,100 options to buy
@ $4.22, valued at
$338k
|
|
| 04/07/2022 |
4
| Trainer John (CFO) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 78,100 options to buy
@ $4.22, valued at
$329.6k
|
|
| 04/07/2022 |
3
| OELKE MATHIAS (Chief Science Officer) has filed a Form 3 on NexImmune, Inc. |
| 03/30/2022 |
4
| Jones Kristi (President and CEO) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 10,000 shares
@ $3.74, valued at
$37.4k
|
|
| 03/28/2022 |
4
| Verstandig Grant (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 39,995 shares
@ $3.35, valued at
$134k
Bought 131,622 shares
@ $4.14, valued at
$544.9k
Bought 18,983 shares
@ $3.76, valued at
$71.4k
|
|
| 03/24/2022 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 10,000 shares
@ $2.6653, valued at
$26.7k
|
|
| 03/23/2022 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 30,000 shares
@ $2.41, valued at
$72.3k
|
|
| 03/22/2022 |
4
| BARER SOL J (Director) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 30,000 shares
@ $2.136, valued at
$64.1k
|
|
|
|
|